Baird lifts target for Cardinal Health stock to USD 276.00

Published on 10/13/2026 at 16:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue rose 5.80 percent to USD 63.67 billion in the quarter reported August 11, 2026. Cardinal Health stock costs EUR 211.80 on October 13, 2026.

Analyst target and reporting date

Baird moved its Cardinal Health target from USD 274.00 to USD 276.00 on October 12, 2026.
Revenue in the reported quarter rose 5.80 percent to USD 63.67 billion.
Cardinal Health stock costs EUR 211.80 at Lang & Schwarz on October 13, 2026 at 4:33 p.m. CEST.
First-quarter fiscal 2027 results are scheduled for November 5, 2026.

Isometrische 3D-Illustration der Pharma-Lieferkette von Produktion bis Apotheke — Isometrisches 3D-Diagramm der Lieferkette von Cardinal Health Inc. – Medizinprodukte ISIN US14149Y1082, Illustration mit AI erstellt.

Baird lifted its Cardinal Health target from USD 274.00 to USD 276.00 on October 12, 2026, according to Moomoo. The new target stands 16.54 percent above the NYSE price of USD 236.82 on October 13, 2026. Cardinal Health stock was trading at EUR 211.80 at Lang & Schwarz on October 13, 2026 at 4:33 p.m. CEST.

Revenue rose in the reported quarter

Cardinal Health reported quarterly revenue of USD 63.67 billion, up 5.80 percent from the year-earlier period, according to MarketBeat. The same report cited quarterly earnings per share of USD 2.91 against a USD 2.42 consensus estimate, while fiscal 2027 adjusted earnings-per-share guidance stood at USD 12.40 to USD 12.60.

The revenue comparison matters because distribution growth is translating into higher scale even as the company operates on a narrow net margin. For the stock, the USD 276.00 target places analyst expectations above the latest NYSE quote, but it does not change the separate euro quotation used by German investors.

Stock sits below its yearly high

On the NYSE, Cardinal Health was last at USD 236.82 at 10:38 a.m. ET on October 13, 2026. Its USD 151.87 to USD 258.30 52-week range places the quote 8.32 percent below the high, while volume stood at 312,469 shares against an average of 1,841,339.

The current Lang & Schwarz bid was EUR 211.20 and the ask was EUR 212.40 at 4:33 p.m. CEST. That spread gives investors a direct view of liquidity in the German trading session, while the home-market quote supplies the currency-consistent range and valuation context.

Valuation and November reporting date

Cardinal Health had a market capitalization of USD 55.5 billion and a trailing P/E ratio of 32.76 on October 13, 2026. The company operates in healthcare and medical distribution, with pharmaceutical and medical businesses serving pharmacies, hospitals and other care providers.

Cardinal Health is scheduled to report first-quarter fiscal 2027 results on November 5, 2026, according to Simply Wall St. The date gives the next formal checkpoint for testing the USD 12.40 to USD 12.60 adjusted earnings-per-share outlook.

Comparison with peers

Cardinal Health (NYSE, USD): P/E 32.76, market capitalization USD 55.5 billion.

McKesson (NYSE, USD): plus 0.37 percent, P/E 25.69, market capitalization USD 112.3 billion.

Cencora (NYSE, USD): plus 0.77 percent, P/E 24.38, market capitalization USD 63.7 billion.

Euro quote remains the German reference

Cardinal Health was trading at EUR 211.80 at Lang & Schwarz on October 13, 2026 at 4:33 p.m. CEST, with a bid of EUR 211.20 and an ask of EUR 212.40. The further course of trading is shown by the continuously updated real-time quote of Cardinal Health stock.